唾液腺肿瘤的发展前景。

IF 503.1 1区医学 Q1 ONCOLOGY

CA: A Cancer Journal for Clinicians Pub Date : 2023-07-25 DOI:10.3322/caac.21807

Conor E. Steuer MD, Glenn J. Hanna MD, Kartik Viswanathan MD, PhD, James E. Bates MD, Azeem S. Kaka MD, Nicole C. Schmitt MD, Alan L. Ho MD, Nabil F. Saba MD

{"title":"唾液腺肿瘤的发展前景。","authors":"Conor E. Steuer MD, Glenn J. Hanna MD, Kartik Viswanathan MD, PhD, James E. Bates MD, Azeem S. Kaka MD, Nicole C. Schmitt MD, Alan L. Ho MD, Nabil F. Saba MD","doi":"10.3322/caac.21807","DOIUrl":null,"url":null,"abstract":"<p>Salivary gland cancers are a rare, histologically diverse group of tumors. They range from indolent to aggressive and can cause significant morbidity and mortality. Surgical resection remains the mainstay of treatment, but radiation and systemic therapy are also critical parts of the care paradigm. Given the rarity and heterogeneity of these cancers, they are best managed in a multidisciplinary program. In this review, the authors highlight standards of care as well as exciting new research for salivary gland cancers that will strive for better patient outcomes.</p>","PeriodicalId":137,"journal":{"name":"CA: A Cancer Journal for Clinicians","volume":null,"pages":null},"PeriodicalIF":503.1000,"publicationDate":"2023-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"The evolving landscape of salivary gland tumors\",\"authors\":\"Conor E. Steuer MD, Glenn J. Hanna MD, Kartik Viswanathan MD, PhD, James E. Bates MD, Azeem S. Kaka MD, Nicole C. Schmitt MD, Alan L. Ho MD, Nabil F. Saba MD\",\"doi\":\"10.3322/caac.21807\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Salivary gland cancers are a rare, histologically diverse group of tumors. They range from indolent to aggressive and can cause significant morbidity and mortality. Surgical resection remains the mainstay of treatment, but radiation and systemic therapy are also critical parts of the care paradigm. Given the rarity and heterogeneity of these cancers, they are best managed in a multidisciplinary program. In this review, the authors highlight standards of care as well as exciting new research for salivary gland cancers that will strive for better patient outcomes.</p>\",\"PeriodicalId\":137,\"journal\":{\"name\":\"CA: A Cancer Journal for Clinicians\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":503.1000,\"publicationDate\":\"2023-07-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"CA: A Cancer Journal for Clinicians\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.3322/caac.21807\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"CA: A Cancer Journal for Clinicians","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.3322/caac.21807","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 1

摘要

唾液腺癌是一种罕见的、组织学多样的肿瘤。它们从懒惰到攻击性不等，可导致显著的发病率和死亡率。手术切除仍然是治疗的支柱，但放射和全身治疗也是护理模式的关键部分。鉴于这些癌症的罕见性和异质性，最好在多学科项目中进行管理。在这篇综述中，作者强调了唾液腺癌的护理标准以及令人兴奋的新研究，这些研究将努力改善患者的预后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

The evolving landscape of salivary gland tumors

查看原文本刊更多论文

The evolving landscape of salivary gland tumors

Salivary gland cancers are a rare, histologically diverse group of tumors. They range from indolent to aggressive and can cause significant morbidity and mortality. Surgical resection remains the mainstay of treatment, but radiation and systemic therapy are also critical parts of the care paradigm. Given the rarity and heterogeneity of these cancers, they are best managed in a multidisciplinary program. In this review, the authors highlight standards of care as well as exciting new research for salivary gland cancers that will strive for better patient outcomes.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

CA: A Cancer Journal for Clinicians 医学-肿瘤学

CiteScore

873.20

自引率

0.10%

发文量

审稿时长

1 months

期刊介绍： CA: A Cancer Journal for Clinicians" has been published by the American Cancer Society since 1950, making it one of the oldest peer-reviewed journals in oncology. It maintains the highest impact factor among all ISI-ranked journals. The journal effectively reaches a broad and diverse audience of health professionals, offering a unique platform to disseminate information on cancer prevention, early detection, various treatment modalities, palliative care, advocacy matters, quality-of-life topics, and more. As the premier journal of the American Cancer Society, it publishes mission-driven content that significantly influences patient care.